{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:03:15Z","timestamp":1787749395675,"version":"build-2784847793"},"reference-count":71,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ygyno.2011.11.043","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T18:34:40Z","timestamp":1323282880000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature"],"prefix":"10.1016","volume":"125","clinical-trial-number":[{"clinical-trial-number":"nct00788671","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01234818","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"J.","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Obermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2011.11.043_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00001703-200202000-00011","article-title":"Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer","volume":"14","author":"Elit","year":"2002","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0015","author":"Victorian Cancer Registry"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0020","series-title":"FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer","first-page":"S105","article-title":"Carcinoma of the corpus uteri","volume":"95 Suppl. 1","author":"Creasman","year":"2006"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0025","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0030","first-page":"1531","article-title":"Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review","volume":"11","author":"Kaaks","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0035","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0147-0272(97)80002-5","article-title":"Endometrial cancer","volume":"21","author":"Greven","year":"1997","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0040","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ijc.24803","article-title":"Incident cancer burden attributable to excess body mass index in 30 European countries","volume":"126","author":"Renehan","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0045","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/1097-0142(194911)2:6<946::AID-CNCR2820020603>3.0.CO;2-D","article-title":"Genesis of endometrial carcinoma","volume":"2","author":"Hertig","year":"1949","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/0002-9378(79)90821-4","article-title":"The precursors of endometrial carcinoma","volume":"135","author":"Sherman","year":"1979","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0055","first-page":"215","article-title":"Endometrial hyperplasia: histologic classification and behavior","volume":"1","author":"Huang","year":"1988","journal-title":"Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0065","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1471-0528.1961.tb02789.x","article-title":"The significance of atypical endometrial hyperplasia","volume":"68","author":"Campbell","year":"1961","journal-title":"J Obstet Gynecol Br Commun"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0070","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0002-9378(66)90447-9","article-title":"Treatment of persistent endometrial hyperplasia with progestins","volume":"96","author":"Wentz","year":"1966","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9378(89)90103-8","article-title":"The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia","volume":"160","author":"Ferenczy","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0080","first-page":"3793","article-title":"Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia","volume":"18","author":"Lindahl","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0085","doi-asserted-by":"crossref","first-page":"349.e1","DOI":"10.1016\/j.ajog.2010.05.004","article-title":"Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk","volume":"203","author":"Leitao","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0090","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","article-title":"Endometrial cancer","volume":"335","author":"Rose","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bpobgyn.2007.08.003","article-title":"Hormonal therapies and gynaecological cancers","volume":"22","author":"Garrett","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0100","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0105","first-page":"1","article-title":"Pathologic indicators of prognosis in endometrial adenocarcinoma: selected aspects emphasizing the GOG experience. Gynecologic Oncology Group","volume":"30","author":"Zaino","year":"1995","journal-title":"Pathol Annu"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0110","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ygyno.2010.12.343","article-title":"Advances in the management of endometrial carcinoma","volume":"120","author":"Leitao","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(10)70143-1","article-title":"Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial","volume":"11","author":"Mourits","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ijgc-00009577-200503000-00022","article-title":"Total laparoscopic hysterectomy versus total abdominal hysterectomy for obese women with endometrial cancer","volume":"15","author":"Obermair","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0125","first-page":"853","article-title":"Laparoscopic total abdominal hysterectomy in morbidly obese women. A pilot-phase report","volume":"44","author":"Ostrzenski","year":"1999","journal-title":"J Reprod Med"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-3804(00)80014-6","article-title":"Laparoscopic surgery in obese women with endometrial cancer","volume":"7","author":"Holub","year":"2000","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0135","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1471-0528.2010.02552.x","article-title":"Progestogen treatment options for early endometrial cancer","volume":"117","author":"Cade","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/IGC.0b013e31819c5372","article-title":"Efficacy of megestrol acetate (megace) in the treatment of patients with early endometrial adenocarcinoma: our experiences with 21 patients","volume":"19","author":"Eftekhar","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0145","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/IGC.0b013e31819960ba","article-title":"Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia","volume":"19","author":"Han","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0155","first-page":"217","article-title":"Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations","volume":"22","author":"Imai","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0160","first-page":"365","article-title":"Treatment for complex atypical hyperplasia of the endometrium","volume":"22","author":"Jobo","year":"2001","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3835(01)00462-1","article-title":"Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome","volume":"167","author":"Kaku","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0170","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.fertnstert.2009.07.999","article-title":"Outcomes of conservative therapy for young women with early endometrial adenocarcinoma","volume":"93","author":"Mao","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2006.06.013","article-title":"Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium","volume":"248","author":"Minaguchi","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0180","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/ijgc-00009577-200507000-00012","article-title":"Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger","volume":"15","author":"Ota","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0185","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0029-7844(97)00297-4","article-title":"Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40","volume":"90","author":"Randall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1471-0528.2008.02024.x","article-title":"Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases","volume":"116","author":"Signorelli","year":"2009","journal-title":"BJOG"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0195","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1200\/JCO.2006.08.8344","article-title":"Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women","volume":"25","author":"Ushijima","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0200","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/humrep\/dem088","article-title":"Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer","volume":"22","author":"Yamazawa","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2005.06.018","article-title":"Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer","volume":"99","author":"Yang","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0210","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.fertnstert.2009.06.013","article-title":"Fertility-preserving treatment in young women with well-differentiated endometrial carcinoma and severe atypical hyperplasia of endometrium","volume":"92","author":"Yu","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0215","doi-asserted-by":"crossref","first-page":"547.e1","DOI":"10.1016\/j.ajog.2010.07.037","article-title":"Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis","volume":"203","author":"Gallos","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0220","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000089974","article-title":"Fertility-preserving treatment in young women with endometrial cancer","volume":"46","author":"B\u00f6ing","year":"2006","journal-title":"Gynakol Geburtshilfliche Rundsch"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0225","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/09513590902733733","article-title":"The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: a debated therapeutic option","volume":"25","author":"Gadducci","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0230","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mob.2002.122130","article-title":"Intrauterine progesterone treatment of early endometrial cancer","volume":"186","author":"Montz","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0235","author":"Pezzullo"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0240","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/PAS.0b013e31802d68ce","article-title":"Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"31","author":"Wheeler","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0245","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00016340903556006","article-title":"Prognostic significance of estrogen and progesterone receptor expression in LNG-IUS (Mirena) treatment of endometrial hyperplasia: an immunohistochemical study","volume":"89","author":"Akesson","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0250","first-page":"580","article-title":"Levonorgestrel-releasing intrauterine system (Mirena) as a therapy for endometrial hyperplasia and carcinoma","volume":"82","author":"Bahamondes","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0255","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejogrb.2005.09.004","article-title":"The management of endometrial hyperplasia: an evaluation of current practice","volume":"125","author":"Clark","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0260","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ygyno.2004.10.031","article-title":"Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature","volume":"97","author":"Dhar","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0265","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s004040000154","article-title":"Metabolic effects associated with high-dose continuous megestrol acetate administration in the treatment of endometrial pathology","volume":"265","author":"Guven","year":"2001","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0270","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ijgc-00009577-200403000-00023","article-title":"Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment","volume":"14","author":"Horn","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0275","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1525-1438.2007.01166.x","article-title":"Serial histologic observation of endometrial adenocarcinoma treated with high-dose progestin until complete disappearance of carcinomatous foci\u2014review of more than 25 biopsies from five patients","volume":"18","author":"Kamoi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0280","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/ijgc-00009577-200801000-00024","article-title":"Loss of phosphatase and tensin homologue deleted on chromosome 10 and phosphorylation of mammalian target of rapamycin are associated with progesterone refractory endometrial hyperplasia","volume":"18","author":"Milam","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0285","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.fertnstert.2010.07.1044","article-title":"Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study","volume":"95","author":"Scarselli","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0290","first-page":"93","article-title":"Conservative management of atypical endometrial hyperplasia and early invasive carcinoma with intrauterine levonorgestrel: a progesterone receptor study","volume":"2","author":"Tjalma","year":"2004","journal-title":"Eur J Cancer Suppl"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0295","first-page":"33","article-title":"Management of endometrial hyperplasia: a retrospective analysis","volume":"82","author":"Triwitayakorn","year":"1999","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0300","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ejogrb.2008.02.022","article-title":"The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia\u2014a long-term follow-up study","volume":"139","author":"Varma","year":"2008","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0305","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ygyno.2003.07.002","article-title":"Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone","volume":"91","author":"Vereide","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0310","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.maturitas.2006.12.004","article-title":"Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up","volume":"57","author":"Wildemeersch","year":"2007","journal-title":"Maturitas"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0315","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humpath.2009.06.012","article-title":"Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins","volume":"41","author":"Witkiewicz","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0320","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/(SICI)1097-0258(19961215)15:23<2493::AID-SIM381>3.0.CO;2-C","article-title":"Models for estimating the number of unpublished studies","volume":"15","author":"Gleser","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0325","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1479-828X.2009.00981.x","article-title":"The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review","volume":"49","author":"Buttini","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0330","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ajog.2011.01.025","article-title":"Fertility preserving options in patients with gynecologic malignancies","volume":"205","author":"Eskander","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0335","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ygyno.2008.02.027","article-title":"Stage IV endometrial cancer after failed conservative management: a case report","volume":"111","author":"Kothari","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0340","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jmig.2008.08.016","article-title":"Endometrioid adenocarcinoma after insertion of a levonorgestrel-releasing intrauterine system","volume":"15","author":"Flemming","year":"2008","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0345","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/gyno.2002.6817","article-title":"Endometrial adenocarcinoma following the insertion of a Mirena IUCD","volume":"87","author":"Jones","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0350","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2010.10.004","article-title":"Conservative treatment of early endometrial cancer: preliminary results of a pilot study","volume":"120","author":"Laurelli","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0355","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2008.07.076","article-title":"Multi-institutional study identifying predictors of response to progestin treatment of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma","volume":"111","author":"Penner","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2011.11.043_bb0360","author":"U.S. National Institutes of Health"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811009656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825811009656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:29:44Z","timestamp":1758770984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825811009656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0090825811009656"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.043","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}